To the Editor: The one-stage prothrombin time played a significant part in the development of the modern clinical approach to the hemorrhagic diseases. This is again illustrated by the paper of Kroll ...
THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results